← FDA DRUG APPROVALS

FDA ANDA · ANDA076349

FLUDARABINE PHOSPHATE

Sponsor: HIKMA

APPLICATION
ANDA076349
TYPE
ANDA
ORIGINAL APPROVAL
2003-08-28
LATEST ACTION
2011-12-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FLUDARABINE PHOSPHATEPrescription
FLUDARABINE PHOSPHATE 50MG/VIAL · INJECTABLE · INJECTION

Approval history

2011-12-08Labeling · Supplement 14AP
2011-03-21Labeling · Supplement 4AP
2003-08-28OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →